Amplification of Her-2/neu oncogene in GERD-Barrett's metaplasia - dysplasia - adenocarcinoma sequence

Hepato-Gastroenterology

Volumn 60, Issue 125, 2013, Pages 1063-1066

  Mokrowiecka, Anna ^a   Wierzchniewska Lawska, Agnieszka ^a   Smolarz, Beata ^b   Romanowicz Makowska, Hanna ^b   Lochowski, Mariusz ^a   Kozak, Jozef ^a   Malecka Panas, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Adenocarcinoma; Barrett's esophagus; Her 2 neu; Reflux

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; FEMALE; GASTROESOPHAGEAL REFLUX; GENE AMPLIFICATION; HUMAN; INTESTINE METAPLASIA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 84885762021     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge121343     Document Type: Article

References (21)

1. Rossi E, Villanacci V, Bassotti G, et al.: Her-2/neu in barrett esophagus: a comparative study between histology, immunohistochemistry, and fluorescence in situ hybridization. Diagn Mol Pathol 2006; 15:125-130. (Pubitemid 44325472)
2. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P: Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365:1375-1383.
3. Geddert H, Zeriouh M, Wolter M, et al.: Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions. Am J Clin Pathol 2002; 118:60-66. (Pubitemid 34734253)
4. Ross JS, McKenna BJ: The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 2001; 19:554-568. (Pubitemid 32619394)
5. Arrington AK, Dahlberg PS, Davydova J, Vickers SM, Yamamoto M: ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas. Surgery 2009; 146:213-219.
6. Dahlberg PS, Jacobson BA, Dahal G, et al.: ERBB2 amplifications in esophageal adenocarcinoma. Ann Thorac Surg 2004; 78:1790-1800. (Pubitemid 39423556)
7. Walch A, Specht K, Bink K, et al.: Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia- adenocarcinoma sequence of Barrett's esophagus. Lab invest 2001; 81:791-801. (Pubitemid 32553401)
8. Hicks DG, Whitney-Miller C: HER2 testing in gastric and gastroesophageal junction cancers: a new therapeutic target and diagnostic challenge. Appl Immunohistochem Mol Morphol 2011; 19:506-508.
9. Hjortland GO, Meza-Zapeda LA, Beiske K, et al.: Genome wide single cell analysis of chemiotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma. BMC Cancer 2011; 11:455.
10. al-Kasspooles M, Moore JH, Orringer MB, Beer DG: Amplification and over-expression of the EGFR and erb-2 genes in human adenocarcinomas. Int J Cancer 1993; 54:213-219. (Pubitemid 23154884)
11. Persons DL, Bui MM, Lowery MC, et al.: Fluorescence in situ hibridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study. Ann Clin Lab Sci 2000; 30:41-48. (Pubitemid 30078303)
12. Chiang PW, Beer DG, Wei WL, Orringer MB, Kurnit DM: Detection of c-erbB-2 amplification in tumors and sera from esophageal carcinoma patients. Clin Cancer Res 1999; 5:1381-386. (Pubitemid 29282942)
13. Brien TP, Odze RD, Sheehan CE, et al.: Her-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma. Hum Pathol 2000; 31:35-39. (Pubitemid 30054384)
14. Walch A, Bink K, Gais P, et al.: Evaluation of c-erbB-2 overexpression and Her-2/neu gene copy number heterogeneity in Barrett's adenocarcinoma. Anal Cell Pathol 2000; 20:25-32.
15. KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol 2006; 59:631-634.
16. Jankowski J, Murphy S, Coghill G, et al.: Epidermal growth factor receptors in the oesophagus. Gut 1992; 33:439-443.
17. Flejou JF, Paraf F, Muzeau F, et al.: Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: Pathological and prognostic correlations. J Clin Pathol 1994; 47:23-26. (Pubitemid 24057743)
18. Reid BJ, Haggitt RC, Rubin CE, et al.: Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19:166-178. (Pubitemid 18091022)
19. Jankowski J, Mcmenemin R, Penston J, Hopwood D, Wormsley KG: Regulatory growth peptides in Barrett's mucosa. Clin Sci 1991; 81:663-668.
20. Yoon HH, Shi Q, Sukov WR, et al.: Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas. Clin Cancer Res 2012; 18:546-554.
21. Hechtman JF, Polydorides AD: HER2/neu gene amplification and protein. Overexpression in gastric and gastroesophageal junction adenocarcinoma. A Review of histopathology, diagnostic testing, and clinical implications. Arch Pathol Lab Med 2012; 136:691-697.